October 23, 2016 6:36 AM ET


Company Overview of Supernus Pharmaceuticals, Inc.

Executive Profile

Georges Gemayel Ph.D.

AgeTotal Calculated CompensationThis person is connected to 11 Board Members in 11 different organizations across 16 different industries.

See Board Relationships


Dr. Georges Gemayel, Ph.D., has been the Chairman of the Board at Orphazyme ApS since August 2014. He has been Non-Executive Chairman of Enterome SA since September 2015. He has been the Chairman of OxThera AB since February 2014. He serves as the Chairman of the Board of Directors at Enterome Bioscience. He serves as the Chairman of Vascular Magnetics, Inc., and Syndexa Pharmaceuticals Corp. Dr. Gemayel has been an Independent Director of Dimension Therapeutics, Inc. ...

Corporate Headquarters

1550 East Gude Drive
Rockville, Maryland 20850

United States

Phone: 301-838-2500
Fax: --

Board Members Memberships

Member of The Board of Directors
Chairman of The Board
Director, Member of Audit Committee and Member of Governance & Nominating Committee
Director, Chairman of Pipeline Steering Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
Non-Executive Chairman
Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee


Université Paris-Sud, Paris XI
Saint Joseph University Beirut Lebanon

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$31,200
Total Calculated Compensation$259,926

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Richard F. Pops Chairman and Chief Executive Officer
Alkermes plc
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
James A. Schoeneck Chief Executive Officer, President and Director
Depomed, Inc.
Craig A. Collard Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
Alessandro E. Della Chà LL.MChief Executive Officer and Executive Director
Cosmo Pharmaceuticals N.V.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Supernus Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.